Business
Genmab Announces Initiation of Share Buy-Back Program
Company Announcement Repurchase of up to 342,130 shares with a maximum aggregate total value of 725 million DKK Honoring our commitments under the Restricted Stock Unit programCompletion expected no later than March 31, 2026 COPENHAGEN, Denmark; February 17, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that it is initiating a share buy-back program, to honor our commitments under the Restricted Stock Unit program. The share buy-back program will be undertaken on the terms set out below and i
About this update from Genmab A/s
[{"type":"image","alt":"Genmab A/S","displaySize":"","headline":null,"caption":"Genmab A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":275,"height":85,"url":"https://media.zenfs.com/en/globenewswire.com/c0cd563151331363bc069dc3ced1531d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3fXMaEmkURmdIw8oGLJV.g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c0cd563151331363bc069dc3ced1531d","width":275,"height":85}},"lazy":false},{"type":"text","content":"Company Announcement","length":20,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Repurchase of up to 342,130 shares with a maximum aggregate total value of 725 million DKK ","length":90,"tagName":"p"}]},{"val":[{"type":"text","content":"Honoring our commitments under the Restricted Stock Unit program","length":64,"tagName":"p"}]},{"val":[{"type":"text","content":"Completion expected no later than March 31, 2026 ","length":48,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":202,"olType":false},{"type":"text","content":"COPENHAGEN, Denmark; February 17, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that it is initiating a share buy-back program, to honor our commitments under the Restricted Stock Unit program. The share buy-back program will be undertaken on the terms set out below and in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” ","length":436,"tagName":"p"},{"type":"text","content":"Time frame The share buy-back program will start on February 18, 2026, and is expected to end no later than March 31, 2026 (unless Genmab terminates or suspends the program). ","length":181,"tagName":"p"},{"type":"text","content":"TermsGenmab has entered into a non-discretionary instruction with Danske Bank in relation to the share buy-back program. Danske Bank will make its own trading decisions and act independently of and without influence or involvement from Genmab. Under this share buy-back program Genmab may repurchase up to 342,130 shares with a maximum aggregate total value of 725 million DKK.","length":378,"tagName":"p"},{"type":"text","content":"Any purchase of ordinary shares done in relation to this announcement will be carried out on Nasdaq Copenhagen and Multilateral Trading...